Albumin–protamine–oligonucleotide nanoparticles as a new antisense delivery system. Part 1: Physicochemical characterization
- 1 April 2005
- journal article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 59 (3) , 419-429
- https://doi.org/10.1016/j.ejpb.2004.04.001
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Cellular delivery of antisense oligonucleotidesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2000
- Antisense Oligonucleotide Delivery with Polyhexylcyanoacrylate Nanoparticles as CarriersMethods, 1999
- Nucleic Acid Therapeutics: State of the Art and Future ProspectsBlood, 1998
- Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotidesJournal of Controlled Release, 1998
- Cationic Polyhexylcyanoacrylate Nanoparticles as Carriers for Antisense OligonucleotidesAntisense and Nucleic Acid Drug Development, 1997
- Protamine sulfate enhances lipid-mediated gene transferGene Therapy, 1997
- Protamine Sulfate Provides Enhanced and Reproducible Intravenous Gene Transfer by Cationic Liposome/DNA ComplexJournal of Liposome Research, 1997
- Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide.Proceedings of the National Academy of Sciences, 1978
- Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide.Proceedings of the National Academy of Sciences, 1978
- About the role of protamine in transfectionBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1973